FCE-27164

FCE-27164 is a therapeutic agent that inhibits the binding of platelet-derived growth factor beta and interleukin-7 (IL-7) to their respective receptors, potentially modulating inflammatory and immune responses.

[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cn1cc(NC(=O)Nc2cc(C(=O)Nc3cc(C(=O)Nc4cc(c5cc(cc(c5c4)S([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O)n(C)c3)n(C)c2)cc1C(=O)Nc1cc(C(=O)Nc2cc(c3cc(cc(c3c2)S([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O)n(C)c1